关键词: Hematoporphyrin monomethyl ether-mediated photodynamic therapy Phakomatosis pigmentovascularis Pruritus

Mesh : Adult Child Hematoporphyrins / therapeutic use Humans Neurocutaneous Syndromes Photochemotherapy / methods Photosensitizing Agents / therapeutic use Port-Wine Stain / drug therapy Pruritus / drug therapy Quality of Life

来  源:   DOI:10.1016/j.pdpdt.2021.102180   PDF(Sci-hub)

Abstract:
Phakomatosis pigmentovascularis (PPV) is a rare congenital syndrome characterized by (a) capillary malformations, such as port-wine stain (PWS), and (b) pigmented lesions, such as pigmented trichoepidermal nevus, café-au-lait spots, and dermal melanocytosis with or without systemic damage. Severe pruritus has not previously been reported among PPV patients. Here, we report a pediatric case of PPV with severe pruritus, which was refractory to various long-term oral antiallergic agents and topical tacrolimus but was temporarily responsive to hematoporphyrin monomethyl ether-mediated photodynamic therapy (HMME-PDT). HMME-PDT is the latest technology used in treating PWS following the basic principle of targeted photodynamic destruction of the vascular wall of the lesion. Furthermore, many studies have confirmed the safety and efficacy of HMME-PDT for PWS in both adults and children. Specific pathophysiologic mechanisms and treatment methods must be further explored to advance our understanding of the disease and improve the quality of life in PPV patients.
摘要:
暂无翻译
公众号